Skip to main content

Benkowitz Michael's Form 4 filing

United Therapeutics Corp (UTHR) · filed Sep 24, 2025

Accession no.
0001673232-25-000004
Filed
Sep 24, 2025
Trade date
Sep 22, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $9.37M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benkowitz MichaelCIK 0001673232Officer (PRESIDENT AND COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 22, 2025Common StockMOption exerciseAcquired+14,625$135.42+$1,980,517.514,625Indirect
Sep 22, 2025Common StockSSaleDisposed−14,625$416.35−$6,089,118.750Indirect
Sep 22, 2025Common StockMOption exerciseAcquired+7,875$146.03+$1,149,986.257,875Indirect
Sep 22, 2025Common StockSSaleDisposed−7,875$416.35−$3,278,756.250Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 22, 2025Common StockMOption exerciseDisposed−14,625$0.00$0129,000Indirect
Sep 22, 2025Common StockMOption exerciseDisposed−7,875$0.00$033,250Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)